• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信使核糖核酸——从新冠治疗到癌症免疫疗法

mRNA-From COVID-19 Treatment to Cancer Immunotherapy.

作者信息

Krause Werner

机构信息

Independent Researcher, 13505 Berlin, Germany.

出版信息

Biomedicines. 2023 Jan 22;11(2):308. doi: 10.3390/biomedicines11020308.

DOI:10.3390/biomedicines11020308
PMID:36830845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9953480/
Abstract

This review provides an overview covering mRNA from its use in the COVID-19 pandemic to cancer immunotherapy, starting from the selection of appropriate antigens, tumor-associated and tumor-specific antigens, neoantigens, the basics of optimizing the mRNA molecule in terms of stability, efficacy, and tolerability, choosing the best formulation and the optimal route of administration, to summarizing current clinical trials of mRNA vaccines in tumor therapy.

摘要

本综述概述了信使核糖核酸(mRNA)从其在新冠疫情中的应用到癌症免疫治疗的情况,内容涵盖从选择合适的抗原(肿瘤相关抗原、肿瘤特异性抗原、新抗原),到在稳定性、有效性和耐受性方面优化mRNA分子的基础知识,再到选择最佳配方和最优给药途径,直至总结mRNA疫苗在肿瘤治疗中的当前临床试验情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/9f739fd8df7d/biomedicines-11-00308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/7e5c698d6c7d/biomedicines-11-00308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/23e3e7487431/biomedicines-11-00308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/e2174c64cb1a/biomedicines-11-00308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/9f739fd8df7d/biomedicines-11-00308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/7e5c698d6c7d/biomedicines-11-00308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/23e3e7487431/biomedicines-11-00308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/e2174c64cb1a/biomedicines-11-00308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52d/9953480/9f739fd8df7d/biomedicines-11-00308-g004.jpg

相似文献

1
mRNA-From COVID-19 Treatment to Cancer Immunotherapy.信使核糖核酸——从新冠治疗到癌症免疫疗法
Biomedicines. 2023 Jan 22;11(2):308. doi: 10.3390/biomedicines11020308.
2
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
3
Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development.鉴定剪接变异衍生的癌症新抗原用于 mRNA 疫苗开发。
Brief Bioinform. 2022 Mar 10;23(2). doi: 10.1093/bib/bbab553.
4
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers.靶向新抗原以诱导针对癌症的T细胞免疫的治疗性疫苗。
Pharmaceutics. 2022 Apr 15;14(4):867. doi: 10.3390/pharmaceutics14040867.
5
Engineering neoantigen vaccines to improve cancer personalized immunotherapy.工程化 neoantigen 疫苗以改善癌症个体化免疫治疗。
Int J Biol Sci. 2022 Sep 1;18(15):5607-5623. doi: 10.7150/ijbs.76281. eCollection 2022.
6
Targeting neoantigens for cancer immunotherapy.针对新抗原的癌症免疫疗法。
Biomark Res. 2021 Jul 28;9(1):61. doi: 10.1186/s40364-021-00315-7.
7
Neoantigen: A New Breakthrough in Tumor Immunotherapy.肿瘤免疫治疗新突破:新抗原
Front Immunol. 2021 Apr 16;12:672356. doi: 10.3389/fimmu.2021.672356. eCollection 2021.
8
Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines.超越测序:优先考虑和提供用于癌症疫苗的新抗原。
Methods Mol Biol. 2022;2410:649-670. doi: 10.1007/978-1-0716-1884-4_35.
9
Neoantigens and their potential applications in tumor immunotherapy.新抗原及其在肿瘤免疫治疗中的潜在应用。
Oncol Lett. 2022 Mar;23(3):88. doi: 10.3892/ol.2022.13208. Epub 2022 Jan 21.
10
Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.鉴定癌细胞中的新抗原作为免疫治疗的靶点。
Int J Mol Sci. 2022 Feb 26;23(5):2594. doi: 10.3390/ijms23052594.

引用本文的文献

1
Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis.通过离子电渗法进行裸mRNA疫苗的皮内递送。
Pharmaceutics. 2023 Nov 26;15(12):2678. doi: 10.3390/pharmaceutics15122678.
2
The Role of Human Endogenous Retroviruses in Cancer Immunotherapy of the Post-COVID-19 World.人类内源性逆转录病毒在新冠疫情后世界癌症免疫治疗中的作用
Cancers (Basel). 2023 Nov 7;15(22):5321. doi: 10.3390/cancers15225321.
3
Bibliometric analysis of RNA vaccines for cancer.癌症 RNA 疫苗的文献计量分析。

本文引用的文献

1
Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8 T cell response.脂质纳米颗粒介导的 mRNA 癌症疫苗淋巴结靶向递送引发强烈的 CD8 T 细胞反应。
Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2207841119. doi: 10.1073/pnas.2207841119. Epub 2022 Aug 15.
2
Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine.分析黑色素瘤肿瘤抗原和免疫亚型,为 mRNA 疫苗的开发提供依据。
Invest New Drugs. 2022 Dec;40(6):1173-1184. doi: 10.1007/s10637-022-01290-y. Epub 2022 Aug 13.
3
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2231333. doi: 10.1080/21645515.2023.2231333. Epub 2023 Jul 18.
鉴定用于mRNA疫苗开发的恶性间皮瘤肿瘤抗原和免疫亚型
Vaccines (Basel). 2022 Jul 22;10(8):1168. doi: 10.3390/vaccines10081168.
4
Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.胃腺癌 mRNA 疫苗免疫亚型的综合分析。
Front Immunol. 2022 Jul 7;13:827506. doi: 10.3389/fimmu.2022.827506. eCollection 2022.
5
Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development.胶质母细胞瘤的肿瘤抗原与免疫亚型:mRNA疫苗及个体化免疫治疗发展的基础
J Big Data. 2022;9(1):92. doi: 10.1186/s40537-022-00643-x. Epub 2022 Jul 14.
6
Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma.鉴定用于开发免疫冷型间皮瘤mRNA疫苗的潜在抗原
Front Cell Dev Biol. 2022 Jul 1;10:879278. doi: 10.3389/fcell.2022.879278. eCollection 2022.
7
Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development.鉴定新型肿瘤抗原及膀胱癌患者的免疫图谱以用于mRNA疫苗开发。
Front Oncol. 2022 Jun 24;12:921711. doi: 10.3389/fonc.2022.921711. eCollection 2022.
8
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.mRNA 疫苗:癌症免疫治疗新时代的曙光。
Front Immunol. 2022 Jun 2;13:887125. doi: 10.3389/fimmu.2022.887125. eCollection 2022.
9
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines.mRNA 疫苗在治疗新冠病毒到肿瘤治疗范式转变。
Cancer Treat Rev. 2022 Jun;107:102405. doi: 10.1016/j.ctrv.2022.102405. Epub 2022 May 5.
10
The clinical progress of mRNA vaccines and immunotherapies.mRNA 疫苗和免疫疗法的临床进展。
Nat Biotechnol. 2022 Jun;40(6):840-854. doi: 10.1038/s41587-022-01294-2. Epub 2022 May 9.